drugset / Trial / NCT02321397
To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain
RandomizedCrossoverDouble-blindTreatment
Summary
This study is aimed to demonstrate equivalence between combinations of lower strength OXN PR tablets (OXN PR LST) and single higher strength OXN PR tablets (OXN PR HST) taken at the same overall daily dose.
Timeline
- Start
- 2014-11
- Primary completion
- 2016-03
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Naloxone | Small molecule | 60 mg | — |
| Comparator | Naloxone | Small molecule | 80 mg | — |
| Subject | Oxycodone | Other / unclassified | 120 mg | — |
| Subject | Oxycodone | Other / unclassified | 160 mg | — |
Indications
No indication recorded.